Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05480306
Title Phase 2 Study of DKN-01 in Colorectal Cancer (DeFianCe)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Leap Therapeutics, Inc.
Indications

colorectal cancer

Therapies

Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin

DKN-01 + Fluorouracil + Irinotecan + Leucovorin

Fluorouracil + Irinotecan + Leucovorin

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST